{"name":"Bambusa Therapeutics","slug":"bambusa-therapeutics","ticker":"","exchange":"","domain":"bambusa.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"BBT002","genericName":"BBT002","slug":"bbt002","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"BBT002","genericName":"BBT002","slug":"bbt002","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-03-19","type":"pipeline","source":"The Manila Times","summary":"Bambusa Therapeutics Appoints Todd James Chief Financial Officer - The Manila Times","headline":"Bambusa Therapeutics Appoints Todd James Chief Financial Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxNWHFEMW1KbkpzMFZjcHZyOFFwaVJ5YzlILXJibjJWM0NKSXV6elFvNEttNlNDcFUwQVNOVHNBWXptM1BLZFJsXzNtcVRBSzBvVFIzNXozeDZDYVppOUo2RWFjb2RiYm9GWk9nOGw1VklQX2luUlZ4Zm9JVk1JdzctTzJ3Zzl2OW5SV2JTU0ZGZHp4aWdhbXpOTC1Cc3RXc1diaVZNTDRnb2FlRUx6TG5UemVIeWtiNk52QTI0VDhucnNXYkNzVk1uaHVxM2xRVWNJeldRc3VVaXJCel85SlFUYm1DTXBjdFk5b3FDUmpZM1pKc3ZHYkdCMW51Z2NfVzYw?oc=5","date":"2025-11-17","type":"pipeline","source":"prnewswire.com","summary":"Bambusa Therapeutics Announces Completion of Series A-2 Financing to Accelerate Next-Generation Bispecific Programs - prnewswire.com","headline":"Bambusa Therapeutics Announces Completion of Series A-2 Financing to Accelerate Next-Generation Bispecific Programs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOUTFQWlV2eFdHWXFoM2FnbFJhbjBFZGNiQ1BlMGVNM3NEV3JKeUJEdEM0bDV5NnNqMl93dDhCbVJyVWNia0JlcWJyblJ4am5nWmZiVzdCYUFXTGVGRnlYcWZvb2VReEt0RFRkTVBJTUVIcGVUU3JDNFo0cEJsSkxqSVplUnFrTUNxM3FaWXc0cl80Szc1RUE1R3lhdEZMZGlLR0p1N0RXRDJHZXR4QjB5MjJzTDA0eXc?oc=5","date":"2025-03-05","type":"pipeline","source":"BioCentury","summary":"Bambusa: Combining validated I&I targets in bispecifics to broaden efficacy - BioCentury","headline":"Bambusa: Combining validated I&I targets in bispecifics to broaden efficacy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPaXdJX1pCWEFuZkk4a2dDVklJVkNFOG93bFlQSjRnU3VKUTFkODUyMDA4eXFzcTlNTVhtNDhzNzVGeW5mZjZZSnNzVlNkcmdIWUVNcjlHc2owQmxlendRU0RTdTlEQ0xjaFdLVlQwQnM5Z0QyYi05NGpRcmpkeE1BTFB6OFh1Q3U0ejIwT2dRWE9UNWNzTkhvNW1zenExYmV6MV9ObXctUHhrR0JDdzRzNi1ac184QVU?oc=5","date":"2025-02-28","type":"trial","source":"Clinical Trials Arena","summary":"Bambusa Therapeutics doses first volunteers in Phase I bispecific AD trial - Clinical Trials Arena","headline":"Bambusa Therapeutics doses first volunteers in Phase I bispecific AD trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE9KMGhxZ1RqanFsNXdCU2psUklIbFhBWTdaRDFpNVJKeGtCSGlpRkN4ME9MVkNzNXVOUUFzR2pfQjNKYXV0el9zdnp4eUpRMTE5QzhHQVVnZjFUZ3dpaTdtdWt3?oc=5","date":"2025-02-22","type":"pipeline","source":"The Pharma Letter","summary":"Bambusa Therapeutics - The Pharma Letter","headline":"Bambusa Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQRU9VaUtkMEFnWlRSeVBTV0pqa1JJZGJVY3ZWNTlldzBDREFJcWtCZmtzY2pNbkdkWnpBck5UU2t3R3FvbXpfb0pZOGQ0Q290aFFRRnFwamdIdm1qdHBpRHJpWHZWanM3RWVKRE55VXJTdU5zQnkzclpqdFdzYzdCZlU1U1BBYm1aa0RIU1VvOG5walE?oc=5","date":"2025-02-20","type":"pipeline","source":"The Business Journals","summary":"Petri Dish: One Boston biotech shuts down, another bags $90M - The Business Journals","headline":"Petri Dish: One Boston biotech shuts down, another bags $90M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNc3EtMzN2YmJuQUUyYzhhaGtTQnZJYVQzWXV5RWZXUEp5R0t5S2doZHZycXJINjRWOHdkODhEVzJ4V0lGR01nOXctWFc5ZVI3RmRYV0JENU9kNDJyNU9rV3huaGs4cXVDZUNBb25TNUpCRE82ZkJEWVhQUlh6dGlkdjBZcnJLalU5XzBpaUJWNHEtSFktRDJBc3NqU2xFVFpSUTk5MmlkN0FZX211YnFnTXl2ZnpKMTlEbEE?oc=5","date":"2025-02-17","type":"trial","source":"Pharmaceutical Technology","summary":"Bispecific antibody startup Bambusa raises $90m to fund clinical trials - Pharmaceutical Technology","headline":"Bispecific antibody startup Bambusa raises $90m to fund clinical trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgJBVV95cUxNSnk4ejBHVkIyMjdRdzd1QmFWNU9kSnE3UXR1cjc5THkxcVVEeTlhSTEyZlJkekloYkI0ZDdMeW9iVWhxbGFqcXBiai1YajdEcWFkZUxrYU40MFV4OTN1THRNQjEzb2NEcFZMeEdZR3hhaVl3NVZPQVlxd1Y2eWdOTUJmLXV4WlZfUHRPeTNYMVI3NmZqYjZtUVZuT1VEOXdpZEVEUERTU2RzTHlDTGl5Vm5uaW9TS1pzRUtGS0RoUm80Y3FmVGVxSGFDVVdHSnlpakpCanlhWDNEQXM4U1M5NTBTekE4ZEZxWDZsdlB2bGxjS3VhUW03cXZNNzhDVEVOV1p1THlPVVBWaTRIb3kyYjI4MzR4MHRPRHY4cWx6bG1tZTUzX2NyM3R5dTQwcHRLazVQOXBCRi1xczVpUVE?oc=5","date":"2025-02-14","type":"pipeline","source":"prnewswire.com","summary":"Bambusa Therapeutics Raises Approximately $90 Million in Series A Financing to Advance Next-generation Bispecific Antibodies for Immunology & Inflammation Diseases - prnewswire.com","headline":"Bambusa Therapeutics Raises Approximately $90 Million in Series A Financing to Advance Next-generation Bispecific Antibo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQZnpmTUZSQkw3N1M4V1dmalQ4MVZqM3gtUV85b2NCSHBBckEtVldzaXh4SXRZUW9PcGhzZU1PUG90QW95bWxFOG9KUjV2blVSaFU0OGpZbDZvRUNuYXZwdzR5U21yZHl4aUNfM3FRXzhEZDlOVGw3TnR2bEZYc1lyMGJDcWZEbjVnRE1kWk5CcTc2bmVQUXc?oc=5","date":"2025-02-14","type":"pipeline","source":"Fierce Biotech","summary":"Boston biotech Bambusa banks $90M for next-gen bispecifics - Fierce Biotech","headline":"Boston biotech Bambusa banks $90M for next-gen bispecifics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxOVlZwRTJYZk1HNDZiamdhVlY4dlB0d3dHMlVweFBMazNZbElQOC0ybFJZV0hRSENPSmVFZHFqRkd5cjhxV1pCNk1uLVhWQ2dMX1RCWUJ5VWpRdlJWdm1YWmw3bldWX0RjS09hTFN4UUZjeGZ2YWd5VHZ0emI4VWJHV05zbURMNjBfWGdmN2VzMjFNU0RkVnRTWTI3eWRWdEVVeWdYRWVkN1QtRkZ3cjZMZi1xd1FrdzRPSWM4VXo0NDlfZXdPend5czJPbEQxYnNMWUZMS2tJV0lYYm8?oc=5","date":"2024-09-10","type":"pipeline","source":"BioPharma APAC","summary":"Bambusa Therapeutics Secures $15M in Series Seed Funding to Advance Bispecific Antibody Pipeline - BioPharma APAC","headline":"Bambusa Therapeutics Secures $15M in Series Seed Funding to Advance Bispecific Antibody Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiR0FVX3lxTE53TldkSC13ZzVxNlZVNzM0TV9iYVZFb05yY28xZWd2WHhrb3hFZHF6SkNzbFVKc29jOGkxWlBWX0d1MDlmaTVJ?oc=5","date":"2024-07-15","type":"pipeline","source":"BioSpace","summary":"NextGen: Class of 2026 - BioSpace","headline":"NextGen: Class of 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQWDg2V3NmU29id2laa3F3Z2JzelBSaF9TUUR3VWpNWGg0cTcwUUdmaGxnUkRMaEs4MzJHRTFMaHBfQ0hxTFppLWFEYktvQ092bFB4cWQ5NXhoZUFabTVIcjhqeEF0QzRkTlE3LS1hb25INzItNWVXRG1za2VHZjgzRTdnNVd3NUNLSU5xM2VfVTBvTFJpRTVGeGpJa3k3Z2hWQnliZUZwTQ?oc=5","date":"2017-08-09","type":"pipeline","source":"Fierce Pharma","summary":"Pfizer commits $100M for a gene therapies plant in North Carolina - Fierce Pharma","headline":"Pfizer commits $100M for a gene therapies plant in North Carolina","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}